CAS: 2307249-33-6
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | BAY885 REF: IN-DA01EO7ACAS: 2307249-33-6 | 99% | To inquire | Thu 23 Jan 25 |
 | BAY885 REF: TM-T10479CAS: 2307249-33-6 | 99.83% | 49.00 €~904.00 € | Thu 30 Jan 25 |
 | BAY-885 REF: 3D-HSD24933CAS: 2307249-33-6 | Min. 95% | To inquire | Thu 06 Mar 25 |
Ref: IN-DA01EO7A
| 1mg | 163.00 € | ||
| 5mg | 526.00 € | ||
| 10mg | 557.00 € | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Thursday 23 Jan 2025
BAY885
CAS:2307249-33-6
BAY885 is a new ERK5 inhibitor.
Formula:
C25H28F3N7O2
Purity:
99.83%
Color and Shape:
Solid
Molecular weight:
515.53
Ref: TM-T10479
| 1mg | 49.00 € | ||
| 5mg | 155.00 € | ||
| 10mg | 255.00 € | ||
| 25mg | 561.00 € | ||
| 50mg | 904.00 € | ||
| 1mL*10mM (DMSO) | 171.00 € |
Estimated delivery in United States, on Thursday 30 Jan 2025
BAY-885
CAS:2307249-33-6
BAY-885 is a drug development candidate that has been shown to have potent cytotoxic activity …
Formula:
C25H28F3N7O2
Purity:
Min. 95%
Molecular weight:
515.53 g/mol
Ref: 3D-HSD24933
| 10mg | 803.00 € | ||
| 25mg | 1,232.00 € | ||
| 50mg | 1,970.00 € |
Estimated delivery in United States, on Thursday 6 Mar 2025
